Business intelligence reports for the lab diagnostics industry
Subscribe for Exclusive Access.
Subscriptions & Reports
Interested in multiple copies or more than one of our G2 reports?
Call Sokha at 855-528-6903 or email spearson@g2intelligence.com to discuss pricing.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Diagnostics Pipeline: NeuroQure Launches Test for Early Autism Diagnosis
The skin-based test can be used on children as young as two days old
How Labs Can Lead in Early Detection of Infectious Diseases
Smarter operations, automation, and collaboration can strengthen laboratories’ role in early detection
Overturning of Molecular Test Coverage Denials Varies Widely, According to UCSF Study
Research into independent medical review data in four states show payers’ internal policies affect rates of overturns
Dx Deals: Fulgent Genetics Scores Two Laboratories in a Single Deal
It is acquiring Bako Diagnostics and StrataDx for a combined $55.5 million
FDA Watch: Truvian Health Obtains 10 Additional FDA Clearances for TruVerus Platform
TruVerus is designed to perform a slew of clinical laboratory tests on as few as eight drops of blood
Strategies for Clinical Labs to Get Paid More for Genetic Test Claims in 2026
Part of our Revenue Cycle Management Webinar Series, this event offers ideas to stay ahead of genetic test reimbursement obstacles.
CMS Ends Paper CLIA Certificates and Coupons Effective March 1
Laboratories must register for email-only communications and submit all CLIA fees electronically
Up Next for Labs: PAMA Reporting Window Opens May 1
Cuts to reimbursement rates under PAMA have been pushed back again by Congress, this time to January 2027
AI-Designed Molecular Sensors Could Transform Early Cancer Detection
Advances could signal changes for clinical laboratories and at-home testing
